文献速递脊柱脊髓外科

微创经椎间孔腰椎椎间融合术联合相邻节段椎板切除术治疗I-II度腰椎滑脱伴相邻椎管狭窄的术后相邻节段疾病

Postoperative Adjacent Segment Disease in Minimally Invasive Transforaminal Lumbar Interbody Fusion with Adjacent Laminectomy for Grade I-II Spondylolisthesis and Adjacent Spinal Stenosis.
PubMed 文献 · World Neurosurg · 2024-04-07

本研究回顾性分析2007-2022年单中心34例接受微创经椎间孔腰椎椎间融合术(MISTLIF)联合相邻节段椎板切除术的I-II度腰椎滑脱伴相邻椎管狭窄患者,平均随访23.1个月。3例(8.8%)出现需再手术的临床显著术后相邻节段疾病(ASD),多因素logistic回归未发现ASD与手术协变量相关。作者认为该术式安全,ASD发生率低于开放性融合报道率,与单纯MISTLIF报道率相当。

要点

  • 34例患者中3例(8.8%)发生需再手术的临床显著术后ASD。
  • 多因素logistic回归未发现ASD与手术协变量存在关联。
  • 作者认为该术式ASD发生率低于开放性融合报道率,与单纯MISTLIF相当。

核心结论

  • MISTLIF联合相邻节段椎板切除术显示出良好的安全性,术后ASD发生率低于已发表的开放性融合术后发生率,与已发表的单纯MISTLIF术后ASD发生率相当。
  • 作者认为未来前瞻性研究可能更好地阐明MISTLIF联合相邻节段椎板切除术的耐久性,但回顾性数据提示该术式安全且耐久。

研究设计与样本

  • 回顾性分析2007-2022年单中心接受MISTLIF联合相邻节段椎板切除术治疗I-II度腰椎滑脱伴相邻椎管狭窄的患者。
  • 共34例患者符合标准,平均随访23.1个月;共融合37个节段,行45次椎板切除术。
  • 21例接受单节段椎板切除+单节段MISTLIF,10例接受2节段椎板切除+单节段MISTLIF,2例接受单节段椎板切除+2节段MISTLIF,1例接受2节段椎板切除+2节段MISTLIF。

主要发现

  • 3例(8.8%)患者出现需再手术的临床显著术后ASD。
  • 另有3例患者因其他原因需再手术。
  • 多因素logistic回归未发现ASD发生与任何手术协变量存在关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文为回顾性分析。
  • 原文为单中心研究。
  • 作者指出未来前瞻性研究可能更好地阐明该术式的耐久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Studies have demonstrated increased risk of adjacent segment disease (ASD) after open fusion with adjacent-level laminectomy, with rates ranging from 16%-47%, potentially related to disruption of the posterior ligamentous complex. Minimally invasive surgical (MIS) approaches may offer a more durable result. We report institutional outcomes of simultaneous MIS transforaminal lumbar interbody fusion (MISTLIF) and adjacent-level laminectomy for patients with low grade spondylolisthesis and ASD. METHODS: Retrospective analysis was performed on patients who underwent MISTLIF with adjacent level laminectomy to treat grade I-II spondylolisthesis with adjacent stenosis at a single institution from 2007-2022. RESULTS: A total of 34 patients met criteria, with mean follow-up of 23.1 months. In total, 37 levels were fused and 45 laminectomies performed. In this group, 21 patients received a single level laminectomy and single-level MISTLIF, 10 patients received a 2-level laminectomy and single-level MISTLIF, 2 patients received a single-level laminectomy and 2-level MISTLIF, and 1 patient received a 2-level laminectomy and 2-level MISTLIF. Three (8.8%) patients experienced clinically significant postoperative ASD requiring reoperation. Three other patients required reoperation for other reasons. Multiple logistic regression did not reveal any association between development of ASD and surgical covariates. CONCLUSION: MISTLIF with adjacent-level laminectomy demonstrated a favorable safety profile with rates of postoperative ASD lower than published rates after open fusion and on par with the published rates of ASD from MISTLIF alone. Future prospective studies may better elucidate the durability of adjacent-level laminectomies when performed alongside MISTLIF, but retrospective data suggests it is safe and durable.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wolfson D, Mueller J, Hunt B, et al. Postoperative Adjacent Segment Disease in Minimally Invasive Transforaminal Lumbar Interbody Fusion with Adjacent Laminectomy for Grade I-II Spondylolisthesis and Adjacent Spinal Stenosis. World Neurosurg. 2024. PMID: 38588790. doi:10.1016/j.wneu.2024.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。